Get started
Author

Mario Pessoa

Observed names: Mário Pessoa, Pessôa, Mário
ORCID: 0000-0002-0942-7348
Observed ORCID: 0000-0002-0942-7348
OpenAlex ID: A5111096524
Public Financial Management in Latin America
2015 · Mario Pessoa, Mr. Carlos Pimenta · International Monetary Fund eBooks · 21
PDF
The global academic hepatology capacity index (GAHCI): a multi-source assessment reveals profound disparities across Latin America
2026 · Pablo Coste, Ezequiel Ridruejo, et al. · Annals of Hepatology · 2
#168 - Hepatic Steatosis and Steatohepatitis Predict Atherogenic Risk in Metabolic Dysfunction-associated Steatotic Liver Disease in a Latin American Multicenter Cohort
2026 · Carlos Coronel-Castillo, Fátima Higuera-De-La-Tijera, et al. · Annals of Hepatology
PDF
#153 - Early and Sustained Biochemical Response in Latin American Patients With Autoimmune Hepatitis Patients
2026 · Ludmila Resende, Esteban Dominguez, et al. · Annals of Hepatology
PDF
#20 - Reviral-latam: a Multinational Survey on Viral Hepatitis Elimination in Latin America
2026 · Joaquín Cabezas, Javier Crespo, et al. · Annals of Hepatology
#185 - Geographic Heterogeneity in Primary Biliary Cholangitis Across Latin America: Results From Allatin Cohort
2026 · Claudia Couto, Guilherme Cançado, et al. · Annals of Hepatology
#149 - Dynamic Changes in Steatotic Liver Disease Subtype Classification and Predictors of Advanced Fibrosis in Latin America
2026 · Luis Díaz, Francisco Idalsoaga, et al. · Annals of Hepatology
PDF
#95 - Regional Heterogeneity of Fibrosis Severity and Age-adjusted Fib-4 Performance in a Brazilian Biopsy-proven Masld Cohort
2026 · Cristiane Villela-Nogueira, Cristiane Tovo, et al. · Annals of Hepatology
PDF
#165 - Higher Mediterranean Diet Adherence Is Associated With Lower Liver Fibrosis Risk Across Steatotic Liver Disease Subtypes in Latin America
2026 · Luis Díaz, Francisco Idalsoaga, et al. · Annals of Hepatology
PDF
#158 - Familial Risk of Fibrotic Steatotic Liver Disease in First-degree Relatives of Individuals With Advanced Fibrosis in Latin America
2026 · Luis Díaz, Francisco Idalsoaga, et al. · Annals of Hepatology
PDF
#44 - Diagnostic Performance of the Fatty Liver Index and Fib-4 in Women With Polycystic Ovary Syndrome
2026 · Isabela Bodaczny, Isabel Pereira, et al. · Annals of Hepatology
PDF
Pragmatism should not eclipse validation in expanded HBV management for Latin America: response
2026 · Ezequiel Ridruejo, Mario Pessoa, et al. · Annals of Hepatology
FRI-050 Dynamics of steatotic liver disease subtype classification and predictors of significant fibrosis in Latin America: the STELLA study
2026 · Luis Antonio Diaz, Francisco Idalsoaga, et al. · Journal of Hepatology
FRI-203-YI Roux-en-Y gastric bypass versus sleeve gastrectomy in MASH advanced fibrosis resolution: comparable outcomes
2026 · Ana Luiza Gomes Reis, Isabel Veloso Alves Pereira, et al. · Journal of Hepatology
OS-097 Liver fibrosis is the only predictor of adverse outcomes: time to remove metabolic dysfunction associated steatohepatitis (MASH) resolution as a clinical trial endpoint
2026 · Zobair M. Younossi, Ming-Lung Yu, et al. · Journal of Hepatology
TOP-113 Clinical profile, histologic features, non-invasive test accuracy, and long-term outcomes of lean metabolic dysfunction associated steatotic liver disease (MASLD): insights from the global masld project
2026 · Zobair M. Younossi, Leyla de Avila, et al. · Journal of Hepatology
THU-021 The global academic hepatology capacity index (IGCAH): a multisource assessment reveals profound inequities across Latin America
2026 · Pablo Coste, Ezequiel Ridruejo, et al. · Journal of Hepatology
Custo de tratamento da hepatite C genotipo 1 no Sistema Único de Saúde
2013 · Castelo Filho, Adauto, Pessôa, Mário, et al. · Jornal Brasileiro de Economia da Saúde
PDF
Works count: 18
Citation count: 23
H-index: 2
I10-index: 1
Year
Topic
Type